aTyr Pharma Announces Appointment of Timothy P. Coughlin to its Board of Directors
April 10, 2017 17:00 ET
|
aTyr Pharma Inc.
SAN DIEGO, April 10, 2017 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq:LIFE), a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address severe,...
aTyr Pharma to Present at Needham and Company 16th Annual Healthcare Conference
March 29, 2017 09:00 ET
|
aTyr Pharma Inc.
SAN DIEGO, March 29, 2017 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq:LIFE), a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address severe,...